AMANDA LAMANNA: Open Payments
NPI 1205117751 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,430 in 61 payments from 17 companies in 2025. Trend: 2023 $1,448 · 2024 $1,635 · 2025 $1,430
Food & beverage: $1,358Education: $72
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 6 | $237 |
| Janssen Biotech, Inc. | 7 | $208 |
| Arcutis Biotherapeutics, Inc. | 11 | $191 |
| Novartis Pharmaceuticals Corporation | 5 | $112 |
| LEO Pharma Inc. | 4 | $99 |
| UCB, Inc. | 5 | $97 |
| Amgen Inc. | 5 | $95 |
| Lilly USA, LLC | 3 | $78 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $55 |
| ABBVIE INC. | 3 | $54 |
Products named: DUPIXENT, TREMFYA, Zoryve, ADBRY, Bimzelx, OTEZLA, COSENTYX, EBGLYSS.
Industry payments across AZ — which companies pay providers there.
